Delving into the Latest Updates on Yiqiao Hunan Pharmaceuticals Co. Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Hemic and Lymphatic Diseases

Neoplasms

Herbal medicine

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Herbal medicine	1
Small molecule drug	1

Top 5 Target	Count

HIF-PHs(Hypoxia-inducible factor prolyl hydroxylase)	1

[Translation] A single-center, randomized, open-label, three-period crossover phase I clinical study to evaluate the effects of calcium-containing phosphate binder calcium acetate tablets and non-calcium-containing phosphate binder sevelamer carbonate tablets on the pharmacokinetics of dedostat tablets in healthy subjects

主要目的：评估磷结合剂碳酸司维拉姆片和醋酸钙片对德度司他片药动学的影响。次要目的：观察受试者给予磷结合剂碳酸司维拉姆片和醋酸钙片与德度司他片的安全性。

[Translation]

Primary objective: To evaluate the effect of phosphate binders sevelamer carbonate tablets and calcium acetate tablets on the pharmacokinetics of depo-depo-depo-depo-depo-depo-depo-depo-depo-depo-de- ...

Start Date13 Jul 2023

Sponsor / Collaborator

Yiqiao Hunan Pharmaceuticals Co. Ltd.

CTR20230497 / CompletedPhase 1

一项在健康受试者中评价德度司他片多次给药对盐酸安非他酮缓释片单次给药的药动学影响的单中心、开放、固定序列的I期临床研究

[Translation] A single-center, open-label, fixed-sequence phase I clinical study to evaluate the effect of multiple doses of dedostat tablets on the pharmacokinetics of a single dose of bupropion hydrochloride extended-release tablets in healthy subjects

主要目的：评估德度司他片连续给药后对盐酸安非他酮缓释片药动学特征的影响。次要目的：观察受试者连续给予德度司他片后给予盐酸安非他酮缓释片的安全性。

[Translation]

Primary objective: To evaluate the effect of continuous administration of depo-depo-stat tablets on the pharmacokinetic characteristics of bupropion hydrochloride extended-release tablets. Secondary objective: To observe the safety of bupropion hydrochloride extended-release tablets after continuous administration of depo-depo-stat tablets.

Start Date13 Jun 2023

Sponsor / Collaborator

Yiqiao Hunan Pharmaceuticals Co. Ltd.

CTR20230496 / CompletedPhase 1

一项在健康受试者中评价德度司他片多次给药对瑞舒伐他汀钙片单次给药的药动学影响的单中心、开放、固定序列的I期临床研究

[Translation] A single-center, open-label, fixed-sequence phase I clinical study to evaluate the effect of multiple doses of dedostat tablets on the pharmacokinetics of single doses of rosuvastatin calcium tablets in healthy subjects

主要目的：评估德度司他片连续给药后对瑞舒伐他汀钙片药动学特征的影响；次要目的：观察受试者连续给予德度司他片后给予瑞舒伐他汀钙片的安全性。

[Translation]

Primary objective: To evaluate the effect of continuous administration of depoietin tablets on the pharmacokinetic characteristics of rosuvastatin calcium tablets; Secondary objective: To observe the safety of rosuvastatin calcium tablets after continuous administration of depoietin tablets.

Start Date12 Jun 2023

Sponsor / Collaborator

Yiqiao Hunan Pharmaceuticals Co. Ltd.

100 Clinical Results associated with Yiqiao Hunan Pharmaceuticals Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Yiqiao Hunan Pharmaceuticals Co. Ltd.

Login to view more data

100 Deals associated with Yiqiao Hunan Pharmaceuticals Co. Ltd.

Login to view more data

100 Translational Medicine associated with Yiqiao Hunan Pharmaceuticals Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

NDA/BLA

1

Approved

Login to view more data